Arrowhead Pharmaceuticals (NASDAQ: ARWR) has signed an agreement with an undisclosed third party to acquire a U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE